Loading people...
Ashwin Nandakumar is a Cancer Research UK Post-doctoral Researcher and biotechnology professional based in London and Oxford, United Kingdom. He holds a Doctor of Philosophy in Oncology from the University of Oxford, where he developed his foundational scientific expertise in cancer therapeutics. In his current joint research capacity, he operates across the University of Oxford and the Institute of Cancer Research, focusing on advanced academic oncology research. Beyond his primary academic appointments, Nandakumar possesses hands-on operational experience in the commercial biotechnology sector, specifically in designing and setting up complex oncology clinical trials. He actively applies his scientific domain expertise to advise and operate within early-stage oncology startups across the United Kingdom. His professional background bridges the gap between rigorous academic research and commercialization, maintaining a primary focus on translating cancer therapeutics into viable clinical applications.
Ashwin Nandakumar is Founder at Granza Bio.
Ashwin Nandakumar co-founded Granza Bio.